The Future of Knee Osteoarthritis Treatment: A Breakthrough in Regenerative Injections

By Mr George Tselentakis FRCS(Tr & Orth) PhD

Reborne Longevity is committed to bringing our members the most advanced, evidence-based therapies to support healthy ageing and peak physical performance. One of the most common age-related concerns we see—particularly among active adults and high-performing individuals—is knee osteoarthritis (OA), a degenerative condition that can severely impact mobility and quality of life.

Traditionally, treatment options for OA have been limited to pain management strategies like corticosteroids, hyaluronic acid injections, or, eventually, joint replacement surgery. However, exciting developments in regenerative medicine are reshaping the landscape.

What is Stromal Vascular Fraction (SVF)?

SVF is a potent mixture of regenerative cells derived from a patient’s own fat tissue. It contains:

• Mesenchymal stem cells

• Immune cells

• Growth factors

• Extracellular matrix components

Together, this cellular ecosystem supports inflammation reduction, tissue repair, and even cartilage regeneration—making SVF one of the most promising biologic therapies for osteoarthritis and musculoskeletal rejuvenation.

The Study: Comparing the Most Effective Injections

Researchers examined a wide range of injection therapies used to treat knee OA, including:- Corticosteroids- Hyaluronic acid- Platelet-rich plasma (PRP)- Mesenchymal stem cells (MSCs). The goal was to determine which of these interventions provided the greatest relief from pain and improvement in function over a period of up to 12 months.

Key Findings: Stromal Vascular Fraction Stands Out

• Superior Pain Relief: Stromal Vascular Fraction injections delivered the greatest reduction in pain, outperforming all other therapies, including PRP and MSCs.

• Sustained Results: Patients experienced continuous improvement, with effects lasting up to a full year post-injection.

• Enhanced Joint Function: Not only did Stromal Vascular Fraction reduce pain, but it also significantly improved mobility and joint function, allowing patients to return to an active lifestyle.

What This Means for Reborne Longevity Members

This research aligns with our philosophy at Reborne Longevity: to offer cutting-edge, minimally invasive therapies that restore vitality and extend quality of life. Stromal Vascular Fraction is more than just a treatment for joint pain—it represents a regenerative tool that supports:

• Post-surgical recovery

• Athletic rehabilitation

• Long-term joint preservation

• Inflammation modulation (a key driver of ageing and chronic disease)

• SVF injections may not only help to delay or avoid surgery but also support systemic rejuvenation by modulating inflammation—a key factor in ageing and many chronic diseases.

That’s why Stromal Vascular Fraction therapy is being considered for integration into our Elite Joint Longevity Programme, designed for high-performance individuals and those navigating chronic musculoskeletal challenges.

Is Stromal Vascular Fraction Right for You?

Our clinical team will soon begin offering Stromal Vascular Fraction consultations to select Reborne Longevity members as part of our personalised longevity pathways. If you are experiencing joint pain, have been diagnosed with osteoarthritis, or are seeking proactive regenerative care, we encourage you to speak with one of our orthopaedists during an orthopaedic consultation about your options.

References

Efficacy of Intra-Articular Injections in Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled TrialsBensa A, Previtali D, Sangiorgio A, Boffa A, Salerno M, Filardo G. PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2025 Mar;53(3):745-754. doi: 10.1177/03635465241246524. Epub 2025 Jan 3. PMID: 39751394; PMCID: PMC11874499.

Book a Service